Mclean Hospital
OrganisationROR
People
11 Sept 2026reporter.nih.gov
Director, technical and instrumentation4 Sept 2026reporter.nih.gov
4 Sept 2026reporter.nih.gov
5 May 2026reporter.nih.gov
Professor5 May 2026reporter.nih.gov
Chief, psychotic disorders division12 Dec 2025reporter.nih.gov
Associate professor12 Dec 2025reporter.nih.gov
Trials
Early phase 1Recruiting202680 people1 May 2026clinicaltrials.gov
Phase 2/3Recruiting2024100 people5 Jan 2024clinicaltrials.gov
Phase 4Terminated201711 people12 May 2017clinicaltrials.gov
Phase 1Completed201546 people27 Jan 2015clinicaltrials.gov
Phase 4Completed2015227 people11 Jul 2014clinicaltrials.gov
CollaboratorPhase 3Completed201584 people30 Oct 2013clinicaltrials.gov
Phase 1Completed201012 people12 Jul 2011clinicaltrials.gov
Phase 4Completed201035 people23 Jun 2010clinicaltrials.gov
CollaboratorPhase 1Terminated20064 people23 Oct 2006clinicaltrials.gov
Phase 4Completed200615 people29 May 2006clinicaltrials.gov
Phase 4Completed2006100 people20 Mar 2006clinicaltrials.gov
Phase 2Completed200560 people22 Sept 2005clinicaltrials.gov
Phase 3Completed200532 people2 Aug 2005clinicaltrials.gov
Grants and prizes
K01Computing and deploying normative models for early detection of cerebrovascular deviations predictive of Alzheimer's Disease onsetK01AG098047US$126.9k2026–202911 Sept 2026reporter.nih.gov
R01Data-driven identification of imaging-based and genetic-based hemodynamic biomarkers of Alzheimer's DiseaseR01AG096687US$687.6k2026–20314 Sept 2026reporter.nih.gov
National Institute of Neurological Disorders and Stroke
R01Human iPSC-Based Personalized Cell Therapy of PDR01NS129188US$689.1k2023–20285 May 2026reporter.nih.gov
National Institute of Mental Health
R01Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox BiologyR01MH135093US$889k2024–202812 Dec 2025reporter.nih.gov